Monthly Archives

January 2021



NEW YORK, (January 22, 2021) –  Shelley Tanner, SanovaWorks CEO/President

ODAC Dermatology, Aesthetic and Surgical Conference 2021 – Virtual

At the start of 2020 SanovaWorks and the ODAC Team produced our annual conference in Orlando. This yearly event is a highlight on the dermatology community calendar. As 2020 started to reveal itself, it became clear we would not be able to produce a live event in 2021. For the best interests and the health of our staff, faculty, sponsors, and attendees we made the decision to offer a live virtual event with on-demand access to all sessions with registration.

ODAC Virtual 2021

I would like to personally thank the team that made this all happen. Because of your expertise and hard work, all the marketing, tech support, administrative coordination, and more–paid off. As a result, ODAC 2021 Virtual was one of the most successful ODAC conferences to-date.

Additionally, I want to recognize our faculty, speakers, and sponsorsYour willingness to share your time and expertise was critical to the success of this year’s conference and we hope you have enjoyed being part of it. We are thrilled at the prospect of having you all join us again next year for ODAC 2022–live, in-person, once again.

We are extremely proud of what we have accomplished together, which includes:

  • Nearly 2,000 people tuned in to ODAC  (950+ on the app and an additional 1,000 via workshops)
  • 90% MD/DO Attendees
  • Over 300 ARTE Scholars and residents
  • 20 Sponsor and Exhibiting companies
  • 21 hours of CME
  • ODAC Sneak Peek Inflammatory Diseases Symposium
  • 9 Virtual Solution Rooms
  • 4 CME workshops 
  • 7 sponsored sessions with an average of 200 attendees, peaking at 850 attendees
  • Five-day Board Review Week with 700 residents in attendance
  • 1 million attendee engagements in the event app 
  • 500,000+ minutes of content watched


ODAC Dermatology, Aesthetic and Surgical Conference (ODAC) is a distinguished ACCME accredited dermatology conference designed to meet the needs of medical and aesthetic dermatology providers in the 21st century. Founded in 2003 by dermatology pioneer, Dr. Perry Robins, the ODAC Dermatology Conference provides nearly 700 dermatologists, residents, nurse practitioners, and physician assistants with important annual updates and fresh practical pearls in the field of medical, cosmetic, and surgical dermatology in a highly interactive format.

Dermatologists attend ODAC to stay informed and up-to-date on clinical dermatology updates, new treatments, new uses for old treatments, new product lines, changes to therapeutic guidelines and to witness live demonstrations from the experts. Unique to ODAC, each presentation focuses on practical pearls you can immediately use in your practice.

Attendees of the ODAC Dermatology Conference

  • Discuss the next generation of diagnostic approaches and evidence-based dermatology treatments
  • Observe cutting-edge procedures and techniques with live demonstrations of novel products and emerging technologies
  • Review clinical trial results and discuss case-studies in both large and small group settings
  • Cultivate relationships with colleagues and leaders actively shaping the future of dermatology
  • Earn CME – up to 31 AMA PRA Category 1 Credits™

ODAC recognizes that you hold the vision, highly specialized expertise, and unique training that drives dermatology. ODAC is organized and produced by SanovaWorks.


By | A Note from Shelley

NEW YORK, (January 14, 2021) –  Shelley Tanner, SanovaWorks CEO/President

On January 6, 2021, the unthinkable happened. Our Democracy was attacked at our House, the Capitol Building in Washington, DC. We condemn those actions and those who instigated them in the strongest possible way. Last week’s unacceptable and inexcusable violence at the Capitol shows clearly that the lies and conspiracy theories of a fraudulent 2020 presidential election, perpetuated by elected officials, is not only a reprehensible effort to subvert our Democracy but is dangerous in so many other ways. Our country is weeping. 

After witnessing the violence and speaking individually to staff, friends, and colleagues I sent the below message to our company. I remain committed to my Team and the values and morals that our company and this country are built on. We will get through this, and we will be stronger for it.

Hi Everyone,

It is hard to know what to say but I do know that “this” is not okay.  What happened in the Capitol yesterday is not okay.  It was an act of insurrection and terrorism to our Democracy that has given me a lot to reflect upon and process.

We witnessed a very different show of resistance when you juxtapose it with the protests earlier this year.

No one can tell me that if it had been a group of Black Lives Matter protestors yesterday that they wouldn’t have been treated very differently than the mob that stormed the Capitol.” President-Elect Joe Biden on Twitter this afternoon.

The double standard is not okay. We should not forget about this as we move forward. We must stay committed to action to ensure this is not the case. Period.

That said, yesterday was a bad day for America.  It was a bad day for us all. It was a bad day for many things.  And while the raid on our Capitol, on our Democracy, was not okay – I want you all to know that it is 100% okay to not be okay.  If you need the time and space to cope with yesterday’s events, please let me or your manager know – and we will, of course, make accommodations for you. If you need specific support, please also let us know.

While I am disheartened, after taking a breath, I remain hopeful for a better, more perfect nation.  We are resilient.  We are strong.  And we are better than this. I believe it. Let’s prove it.




NEW YORK, (January 13, 2021) – Luciana Halliday Nofal, VP Marketing and Client Relations SanovaWorks

ODAC Dermatology Aesthetic and Surgical conference 

This year, due to the global pandemic, SanovaWorks is hosting ODAC Dermatology, Aesthetic and Surgical conference, virtually. ODAC is committed to providing high-quality education in an engaging virtual format with top speakers and important topics.

With nearly 1,000 US attendees registered, ODAC will provide a unique virtual experience that will continue to drive dermatology education and networking forward.

We appreciate all the effort that it takes to change direction and to make such an important and impactful event happen. We are deeply grateful to our sponsors, faculty and attendees.

Please take a moment to acknowledge and thank our gracious supporters by visiting their sponsor page in ODAC Virtual app.

Platinum and Featured Sponsors  

Amgen logo

Please see the resources below to discover our data and explore our resources in our sponsor page.


Cassiopea, Inc. is a specialty pharmaceutical company developing and commercializing prescription drugs with novel mechanisms of action to address long-standing and essential dermatological conditions such as acne, androgenetic alopecia and genital warts. Learn more about our company at

Our commitment to dermatology is built around a senior leadership team with deep roots and experience in the specialty. The management team is focused on providing unique treatment options, and to drive continued research and development in Dermatology, moving us to the forefront of the U.S. market.

We are excited to support dermatology healthcare professionals by contributing to the ODAC 2021 Conference.

Galderma, the world’s largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio of prescription medicines, aesthetics solutions and consumer care products. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin. For more information, please visit


Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.

Since 2002, Incyte has remained committed to the relentless pursuit of science that can improve the lives of patients, make a difference in healthcare and build sustainable value for our stakeholders. The Company is advancing a diversified portfolio of clinical candidates across Oncology and Inflammation & Autoimmunity. Our research and development efforts in Dermatology are focused on a number of immune-mediated dermatologic conditions with a high unmet medical need, including atopic dermatitis, vitiligo, and hidradenitis suppurativa.

Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For more information, visit and follow @Incyte.

Visit the Incyte Dermatology Virtual Booth.


Neutrogena Logo

At Aveeno®, groundbreaking science transforms nature’s ingredients into clinically proven products that help soothe, strengthen, and restore the moisture barrier. Our oat, soy, and feverfew ingredients—derived from nature and uniquely formulated to optimize skin health and beauty—are supported by 75 years of published data, demonstrating the scientific rigor behind every result. Visit to learn about our new products, plus access clinical resources, patient resources, and product samples.

The #1 dermatologist recommended skincare brand continually elevates the science of skincare, delivering new products and innovations that support your treatment guidance. Visit to learn what’s new, plus access clinical resources, patient resources, and product samples. – dedicated to dermatology professionals.


La Roche-Posay logo

Our brands are dedicated to dermatology with offerings in professional skincare and cosmetics. Each brand is created by dermatologists or works in partnership with dermatologists to meet the health and safety standards for patients. Please visit the L’Oréal booth.


Novartis logo

Novartis is a leading global medicines company, using innovative science and digital technologies to create treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 109,000 people of more than 145 nationalities work at Novartis around the world. Find out more at

We hope you will take a moment to visit the COSENTYX® (secukinumab) Virtual Booth Experience to learn more about the Complete Cosentyx Approach.


Ortho Dermatologics is a specialty pharmaceutical business with the number one prescribed acne franchise and a portfolio of dermatology treatments in additional therapeutic areas including atopic dermatitis, fungal infections and psoriasis. Led by a team with deep experience in dermatology, we are dedicated to building meaningful connections with healthcare providers and their patients. Our ongoing commitment to the dermatology community shows through our pipeline of novel compounds and focused philanthropic activity here and around the globe.


Regeneron is a leading biotechnology company that invents medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories.

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation around the globe.

Please click the link below to visit our virtual booth!


At UCB, we come together every day to work, laser-focused, on a simple question: How will this create value for people living with severe diseases? Patient value is not just what we say, but how we how we live. It is our culture of care, embodied by our patient value strategy. That’s because how we do business – from discovery to development to delivery – has been transformed and redesigned around the patient and their individual experience. Patients are at the heart of everything we do, inspiring us, driving our scientific discovery, and leading us to rethink the patient experience. By fulfilling our commitment, driving innovation, and providing patients a meaningful experience, more impactful solutions are on the horizon.

With a team of approximately 7,500 employees and operations in nearly 40 countries, we are a global biopharmaceutical company investing more than a quarter of our revenue in cutting-edge scientific research to meet unmet patient needs. Global headquarters are in Brussels, Belgium, with U.S. headquarters in Atlanta, Georgia. Additional U.S. UCB sites include global clinical development in Raleigh, North Carolina, research supporting UCB’s pipeline in Boston, Massachusetts (Bedford and Cambridge), Seattle, Washington, and Durham, North Carolina as part of our acquisition of Element Genomics, as well as an office in Washington, D.C.

CLICK to ENTER Virtual Experience


Official Media Partners